Learn how to switch from semaglutide to tirzepatide, including typical starting doses, side effects to expect, and why there is no official conversion chart.
Switching from semaglutide to tirzepatide means stopping your weekly semaglutide dose and starting tirzepatide — usually at a low dose — on your next scheduled injection day, with a prescriber's approval. There is no FDA-approved semaglutide to tirzepatide conversion chart, so the starting dose is a clinical judgment based on the dose you were taking and how well you tolerated it. Never take both medications in the same week or stack doses to avoid a gap.
Why People Consider Switching
Semaglutide is a GLP-1 receptor agonist, while tirzepatide is a dual GIP and GLP-1 receptor agonist. That difference in mechanism is one reason tirzepatide has produced greater average weight loss in head-to-head research.
The most common reasons people ask about making the change:
- A plateau. Weight loss slows or stops after months at a stable dose.
- Comparison data. In the SURMOUNT-5 trial, tirzepatide produced about 20.2% average weight loss versus about 13.7% for semaglutide 2.4 mg.
- Tolerability. Ongoing nausea, reflux, or fatigue that does not improve.
- Access. Insurance changes, prior authorization rules, or pharmacy shortages.
Interest in "switching from semaglutide to tirzepatide reddit" threads is high because people want real-world stories, but forum anecdotes are not a dosing plan.
Can You Switch From Semaglutide to Tirzepatide?
Yes, you can switch from semaglutide to tirzepatide with a prescriber's approval, and the reverse switch is possible too. Because the two drugs act on overlapping pathways, most clinicians do not require a long washout period; many simply swap the medication on the next weekly injection day.
Three safety rules apply in either direction:
- Do not overlap the two drugs in the same week unless a clinician specifically tells you to.
- Restart at a low dose instead of jumping straight to a higher one.
- Report any history of pancreatitis, gallbladder disease, kidney problems, or diabetic eye disease before switching.
Can you switch from tirzepatide to semaglutide? Yes, and the same principle holds: start low, titrate slowly, and expect appetite suppression to feel somewhat different on the new drug.
Semaglutide to Tirzepatide Conversion: What Doses Look Like
No manufacturer publishes an official semaglutide to tirzepatide dose conversion chart. The table below reflects general patterns discussed in clinical practice, not official guidance, and your prescriber's instructions always take priority.
| Previous weekly semaglutide dose | Commonly considered tirzepatide starting dose | Notes |
|---|---|---|
| 0.25 mg | 2.5 mg | Often treated like a first-time start |
| 0.5 mg | 2.5 mg | Low risk of overlapping side effects |
| 1 mg | 2.5 mg to 5 mg | Depends on tolerability |
| 1.7 mg | 5 mg | Some clinicians still restart at 2.5 mg |
| 2.4 mg (maximum) | 5 mg | A minority start at 7.5 mg; provider-dependent |
After the switch, dosing follows tirzepatide's own labeled titration: 2.5 mg weekly for four weeks, then increases of 2.5 mg roughly every four weeks, up to 15 mg weekly. People searching for "switching from semaglutide to tirzepatide dose" often want one fixed number, but tolerability usually matters more than the number on the old pen.
How to Switch Step by Step
- Get the plan in writing. Ask your prescriber for the exact starting dose and titration schedule.
- Choose the switch day. Most plans use the next scheduled semaglutide injection day.
- Skip the final semaglutide dose. Do not add a partial or "top-up" injection.
- Fill the tirzepatide prescription early. Supply gaps are one of the most common reasons a transition stalls.
- Start at the low dose. Follow the tirzepatide label rather than the semaglutide dose you left behind.
- Track symptoms for a month. Note appetite, nausea, and bowel habits so your provider has data at the follow-up.
- Adjust at four to six weeks. That is typically when a dose increase makes sense.
If you already know how to inject semaglutide, the tirzepatide routine will feel familiar: same subcutaneous sites, same once-weekly rhythm, similar pen or vial technique. Anyone new to the routine should ask a pharmacist to walk through how to take semaglutide or tirzepatide correctly before the first at-home dose.
Side Effects to Expect During the Transition
Both drugs slow gastric emptying, so the side effect profile is similar: nausea, vomiting, diarrhea, constipation, and burping. Switching does not reset your tolerance, so a dose you barely noticed on semaglutide can still cause symptoms when you move to tirzepatide.
- Eat smaller, lower-fat meals during the first two weeks.
- Prioritize protein, fiber, and fluids.
- Contact your prescriber for severe abdominal pain, persistent vomiting, or signs of dehydration.
Rare but serious risks include pancreatitis, gallbladder disease, and low blood sugar when either drug is combined with insulin or sulfonylureas. Talk with a healthcare professional before making any change, especially if you are pregnant, planning pregnancy, or breastfeeding.
Compounded Versions, Cost, and Supply
Brand-name semaglutide and tirzepatide are FDA-approved for specific indications. Compounded semaglutide and tirzepatide are not FDA-approved, and their potency can vary between pharmacies.
If you are comparing compounded options, ask your prescriber how to get compounded semaglutide from a licensed 503A or 503B pharmacy, and whether the same source offers tirzepatide. People who mix their own vials also research how to reconstitute semaglutide and how much bac water to reconstitute 20mg tirzepatide, but reconstitution errors are a genuine source of dosing mistakes. Pre-mixed pens and pharmacy-prepared vials remove that risk.
Cost and coverage often influence the decision more than pharmacology does. Check whether your plan covers tirzepatide for weight management, because prior authorization rules for tirzepatide and semaglutide are frequently different.
SURMOUNT-5 and similar trials suggest tirzepatide is the more potent option on average, but averages do not predict individual results.
Frequently Asked Questions
Can I switch from semaglutide to tirzepatide?
Yes, you can switch from semaglutide to tirzepatide with a prescriber's approval, and most clinicians do not require a long washout period. The typical approach is to skip your next semaglutide dose and start tirzepatide at a low dose on the same weekly schedule. Do not take both medications in the same week unless a clinician tells you to.
What is the semaglutide to tirzepatide dose conversion?
There is no FDA-approved conversion chart for semaglutide to tirzepatide. In clinical practice, people coming from lower semaglutide doses often start tirzepatide at 2.5 mg weekly, while those on 1.7 mg or 2.4 mg of semaglutide may start at 5 mg. Your prescriber should set the exact starting dose based on your history and tolerability.
Should I switch to tirzepatide if I am not losing weight on semaglutide?
A weight loss plateau on semaglutide is common and does not automatically mean you need to switch. Tirzepatide produced greater average weight loss than semaglutide in the SURMOUNT-5 trial, but individual results vary and insurance coverage often differs between the two drugs. Discuss the options with your prescriber before changing medications.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.